Incannex Healthcare (NASDAQ: IXHL) Stock: FDA Fast Track Catalyst, Nasdaq Compliance Clock, and the Latest Forecasts as of Dec. 15, 2025
Incannex Healthcare shares traded near $0.42 early December 15, 2025, after the FDA granted Fast Track designation to its lead sleep apnea drug IHL-42X on December 3. The company also received a Nasdaq bid-price compliance extension to April 2026 and saw updated research coverage from Stonegate Capital Partners in November. Analyst coverage remains limited.